Strides Pharma Science Ltd
NSE:STAR

Watchlist Manager
Strides Pharma Science Ltd Logo
Strides Pharma Science Ltd
NSE:STAR
Watchlist
Price: 1 415.3 INR 1.9% Market Closed
Market Cap: 130.1B INR
Have any thoughts about
Strides Pharma Science Ltd?
Write Note

Intrinsic Value

The intrinsic value of one STAR stock under the Base Case scenario is 1 188.96 INR. Compared to the current market price of 1 415.3 INR, Strides Pharma Science Ltd is Overvalued by 16%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

STAR Intrinsic Value
1 188.96 INR
Overvaluation 16%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Strides Pharma Science Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for STAR cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about STAR?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Strides Pharma Science Ltd

Provide an overview of the primary business activities
of Strides Pharma Science Ltd.

What unique competitive advantages
does Strides Pharma Science Ltd hold over its rivals?

What risks and challenges
does Strides Pharma Science Ltd face in the near future?

Has there been any significant insider trading activity
in Strides Pharma Science Ltd recently?

Summarize the latest earnings call
of Strides Pharma Science Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Strides Pharma Science Ltd.

Provide P/S
for Strides Pharma Science Ltd.

Provide P/E
for Strides Pharma Science Ltd.

Provide P/OCF
for Strides Pharma Science Ltd.

Provide P/FCFE
for Strides Pharma Science Ltd.

Provide P/B
for Strides Pharma Science Ltd.

Provide EV/S
for Strides Pharma Science Ltd.

Provide EV/GP
for Strides Pharma Science Ltd.

Provide EV/EBITDA
for Strides Pharma Science Ltd.

Provide EV/EBIT
for Strides Pharma Science Ltd.

Provide EV/OCF
for Strides Pharma Science Ltd.

Provide EV/FCFF
for Strides Pharma Science Ltd.

Provide EV/IC
for Strides Pharma Science Ltd.

Show me price targets
for Strides Pharma Science Ltd made by professional analysts.

What are the Revenue projections
for Strides Pharma Science Ltd?

How accurate were the past Revenue estimates
for Strides Pharma Science Ltd?

What are the Net Income projections
for Strides Pharma Science Ltd?

How accurate were the past Net Income estimates
for Strides Pharma Science Ltd?

What are the EPS projections
for Strides Pharma Science Ltd?

How accurate were the past EPS estimates
for Strides Pharma Science Ltd?

What are the EBIT projections
for Strides Pharma Science Ltd?

How accurate were the past EBIT estimates
for Strides Pharma Science Ltd?

Compare the revenue forecasts
for Strides Pharma Science Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Strides Pharma Science Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Strides Pharma Science Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Strides Pharma Science Ltd compared to its peers.

Compare the P/E ratios
of Strides Pharma Science Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Strides Pharma Science Ltd with its peers.

Analyze the financial leverage
of Strides Pharma Science Ltd compared to its main competitors.

Show all profitability ratios
for Strides Pharma Science Ltd.

Provide ROE
for Strides Pharma Science Ltd.

Provide ROA
for Strides Pharma Science Ltd.

Provide ROIC
for Strides Pharma Science Ltd.

Provide ROCE
for Strides Pharma Science Ltd.

Provide Gross Margin
for Strides Pharma Science Ltd.

Provide Operating Margin
for Strides Pharma Science Ltd.

Provide Net Margin
for Strides Pharma Science Ltd.

Provide FCF Margin
for Strides Pharma Science Ltd.

Show all solvency ratios
for Strides Pharma Science Ltd.

Provide D/E Ratio
for Strides Pharma Science Ltd.

Provide D/A Ratio
for Strides Pharma Science Ltd.

Provide Interest Coverage Ratio
for Strides Pharma Science Ltd.

Provide Altman Z-Score Ratio
for Strides Pharma Science Ltd.

Provide Quick Ratio
for Strides Pharma Science Ltd.

Provide Current Ratio
for Strides Pharma Science Ltd.

Provide Cash Ratio
for Strides Pharma Science Ltd.

What is the historical Revenue growth
over the last 5 years for Strides Pharma Science Ltd?

What is the historical Net Income growth
over the last 5 years for Strides Pharma Science Ltd?

What is the current Free Cash Flow
of Strides Pharma Science Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Strides Pharma Science Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Strides Pharma Science Ltd

Current Assets 30.9B
Cash & Short-Term Investments 3.4B
Receivables 12.5B
Other Current Assets 15.1B
Non-Current Assets 29B
Long-Term Investments 3.9B
PP&E 10B
Intangibles 11.3B
Other Non-Current Assets 3.7B
Current Liabilities 29.6B
Accounts Payable 9.4B
Other Current Liabilities 20.2B
Non-Current Liabilities 7.5B
Long-Term Debt 6.4B
Other Non-Current Liabilities 1.1B
Efficiency

Earnings Waterfall
Strides Pharma Science Ltd

Revenue
44.1B INR
Cost of Revenue
-17.6B INR
Gross Profit
26.5B INR
Operating Expenses
-19.9B INR
Operating Income
6.7B INR
Other Expenses
-4.4B INR
Net Income
2.3B INR

Free Cash Flow Analysis
Strides Pharma Science Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

STAR Profitability Score
Profitability Due Diligence

Strides Pharma Science Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
ROE is Increasing
Positive 3-Years Revenue Growth
ROIC is Increasing
50/100
Profitability
Score

Strides Pharma Science Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

STAR Solvency Score
Solvency Due Diligence

Strides Pharma Science Ltd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Low D/E
High Altman Z-Score
Long-Term Solvency
Short-Term Solvency
50/100
Solvency
Score

Strides Pharma Science Ltd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

STAR Price Targets Summary
Strides Pharma Science Ltd

Wall Street analysts forecast STAR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for STAR is 1 838.04 INR with a low forecast of 1 666.5 INR and a high forecast of 2 051.7 INR.

Lowest
Price Target
1 666.5 INR
18% Upside
Average
Price Target
1 838.04 INR
30% Upside
Highest
Price Target
2 051.7 INR
45% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for STAR?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for STAR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

STAR Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Strides Pharma Science Ltd Logo
Strides Pharma Science Ltd

Country

India

Industry

Pharmaceuticals

Market Cap

130.1B INR

Dividend Yield

0.18%

Description

Strides Pharma Science Ltd. engages in the development, manufacture and distribution of Internet Protocol-led generics and bio-pharmaceutical products. The company is headquartered in Bangalore, Karnataka. The company went IPO on 2000-02-03. The firm is focused on development and manufacture of IP-led niche and pharmaceutical products. The company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The firm manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as, liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. The company has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). The company is also engaged in manufacturing soft gelatin capsules. The company develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.

Contact

KARNATAKA
Bangalore
Strides House, Bannerghatta Road, Bilekahalli
+918067840000
www.strides.com

IPO

2000-02-03

Employees

2 390

Officers

Founder & Executive Chairperson
Mr. Arun Kumar Pillai B.Com.
MD & Group CEO
Mr. Badree Komandur
Compliance Officer & Company Secretary
Ms. Manjula Ramamurthy
Executive Director of Business Development & Director
Mr. Aditya Arun Kumar
Group CFO & Chief Investor Relations Officer
Mr. Vikesh Kumar
Chief Operating Officer
Mr. P. V. S. Ramaraju
Show More
Group General Counsel, Chief Risk Officer & Chief Sustainability Officer
Sormistha Ghosh
Group Chief Human Resource Officer
Ms. Surabhi Loshali
Executive Vice President of Operations
Mr. C. K. Sundar
Senior Vice President of Strides Pharma Inc.
Mr. Kevin P. Cook
Show Less

See Also

Discover More
What is the Intrinsic Value of one STAR stock?

The intrinsic value of one STAR stock under the Base Case scenario is 1 188.96 INR.

Is STAR stock undervalued or overvalued?

Compared to the current market price of 1 415.3 INR, Strides Pharma Science Ltd is Overvalued by 16%.

Back to Top